Search Results for: FORMULATION DEVELOPMENT TECHNOLOGY A Novel
Articles
February 25, 2013
2/27/2012 February 25, 2013
BASF & Bend Research Sign Bioavailability Agreement BASF SE and Bend Research Inc. have signed an agreement to jointly evaluate...
February 25, 2013
BASF & Bend Research Sign Bioavailability Agreement February 25, 2013
BASF SE and Bend Research Inc. have signed an agreement to jointly evaluate and develop novel excipients to enhance...
February 17, 2013
2/20/2013 February 17, 2013
Argos Therapeutics Announces Updated Phase II Data Argos Therapeutics Inc. recently announced updated results from its Phase II study of...
February 11, 2013
2/13/2013 February 11, 2013
Frost & Sullivan Sees Urgent Need for Cancer Diagnostics Tests; Finds Unmet Need for Key Disorders The range of potential...
January 31, 2013
2/6/2013 January 31, 2013
Foresite Capital Closes $100 Million Fund for Late-Stage Biotechs Biotech venture capital isn't what it used to be, but there's...
January 21, 2013
1/23/2012 January 21, 2013
Amgen Invests $200 Million in Monoclonal Antibodies Amgen recently announced plans to build a new manufacturing facility in the Tuas...
January 14, 2013
1/16/2013 January 14, 2013
BIND Biosciences & Amgen Sign Worldwide Development & Commercialization Agreement BIND Biosciences recently announced it has entered into a global...
December 20, 2012
12/27/2012 December 20, 2012
Radius & 3M Announce Exclusive Agreement Radius Health, Inc. and 3M Drug Delivery Systems recently announced an exclusive partnership agreement...
December 20, 2012
Atlantic Pharmaceuticals Makes Major Announcement December 20, 2012
 Atlantic Pharmaceuticals, Inc. recently announced that new patents have been issued by the USPTO relating to its tamper-resistant SMART/Script...
December 10, 2012
12/12/2012 December 10, 2012
TNF Inhibitors Lay Groundwork for Next-Generation of Disease-Modifying Anti-Rheumatic Drugs The challenges inherent in the pharmacological management of rheumatic diseases...
December 10, 2012
Moderna Therapeutics Secures $40 Million for New Way of Making Therapeutic Proteins December 10, 2012
Moderna Therapeutics recently announced it has closed more than $40 million in financing to date, led by Flagship Ventures and...
November 29, 2012
12/5/2012 November 29, 2012
Curis Announces Several Major Announcements Curis, Inc. recently announced it has licensed from Genentech, a member of the Roche Group,...
November 26, 2012
11/28/2012 November 26, 2012
CoreRx & ViroPro Announce Agreement CoreRx, Inc. and Viropro, Inc. recently announced the two companies have entered into a Reciprocal...
November 19, 2012
11/21/2012 November 19, 2012
Innovative Drugs to Transform Alzheimer's Disease Medication Market The patent expiry of all four existing EMEA-approved drugs for Alzheimer's disease...
November 8, 2012
11/14/2012 November 8, 2012
A Note to The Pharmaceutical Industry Upon The Re-Election of Barack Obama By: Matthew Herper, Forbes Staff, mherper@forbes.com I've covered...
October 25, 2012
10/30/2012 October 25, 2012
Arthritis Signifies a Vast Untouched Market, Finds Frost & Sullivan Tumor necrosis factor (TNF) inhibitors are currently the only therapeutic...
October 21, 2012
10/24/2012 October 21, 2012
Avantor & Rubicon to Collaborate on Next-Generation Functional Excipients Avantor Performance Materials recently announced it has signed a collaboration...
October 11, 2012
10/16/2012 October 11, 2012
Catalent Licenses Innovative Technology Following a successful research collaboration, Catalent Pharma Solutions recently announced it has taken an exclusive license...
October 7, 2012
10/10/2012 October 7, 2012
Cleveland BioLabs & Incuron Announce Orphan Drug Status Cleveland BioLabs, Inc. and Incuron, LLC, a joint venture between the company...
September 16, 2012
9/19/2012 September 16, 2012
PharmaTelevision Spotlights Aptalis' Year in Review FDA approvals, revenue gain, and organic business growth are just a few of the...
